Comanche Biopharma Funding: $75M Raised, Series B (2024)

Comanche Biopharma funding overview

Comanche Biopharma is a Biotech company based in Concord, MA. Comanche Biopharma has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Comanche Biopharma runs through 2024; nothing later has been disclosed. Investors on record include New Enterprise Associates, Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.

Comanche Biopharma at a glance

Total raised: $75M
Latest round: Series B
Latest round date: January 2024
Industry: Biotech
Headquarters: Concord, MA
Notable investors: New Enterprise Associates, Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures, 8VC, ARCH Venture Partners

Frequently asked about Comanche Biopharma funding

How much has Comanche Biopharma raised?: Comanche Biopharma has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Comanche Biopharma?: New Enterprise Associates, Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures are named among the investors backing Comanche Biopharma.
What was the latest Comanche Biopharma funding round?: The most recent disclosed round is a Series B, announced in January 2024.
Where is Comanche Biopharma based?: Comanche Biopharma is based in Concord, MA.
What sector does Comanche Biopharma operate in?: Comanche Biopharma is tracked under Biotech from Concord, MA, with $75M in disclosed funding.
When did Comanche Biopharma last raise?: The last disclosed Comanche Biopharma round closed in January 2024 at Series B.

Comanche Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Concord below to benchmark round size and investor mix.

Comanche Biopharma Funding: $75M Raised, Series B (2024)

Comanche Biopharma funding overview

Comanche Biopharma at a glance

Frequently asked about Comanche Biopharma funding

Comanche Biopharma founders (1)

Companies related to Comanche Biopharma (40)

Browse related funding lists (7)